Acute motor axonal neuropathy: An antibody-mediated attack on axolemma
about
Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosisSystematic reviews of treatment for inflammatory demyelinating neuropathyBiomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be ExploredNeuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies?Neuro-glial interactions at the nodes of Ranvier: implication in health and diseasesSialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regenerationNode of Ranvier disruption as a cause of neurological diseasesAnti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndromeMore severe manifestations and poorer short-term prognosis of ganglioside-associated Guillain-Barré syndrome in Northeast China[Guillain-Barré syndrome after exposure to influenza].Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.Molecular mimicry may contribute to pathogenesis of ulcerative colitis.Comparative genomic analysis of Campylobacter jejuni associated with Guillain-Barré and Miller Fisher syndromes: neuropathogenic and enteritis-associated isolates can share high levels of genomic similarity.New concepts of Guillain-Barré syndrome.Campylobacter species and Guillain-Barré syndrome.Novel therapeutic approaches to Guillain-Barré syndrome.Identification of gene networks and pathways associated with Guillain-Barré syndrome.An update on pathobiologic roles of anti-glycan antibodies in Guillain-Barré syndrome.Axonal Guillain-Barré syndrome: a critical review.Diagnosis of motor neuropathy.Guillain-barré syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder.Paranodal permeability in "myelin mutants".Axonal and perikaryal involvement in chronic inflammatory demyelinating polyneuropathy.Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barré syndrome with antiganglioside antibodies.A variant of multifocal motor neuropathy with acute, generalised presentation and persistent conduction blocks.Anti-Ganglioside Antibodies Induce Nodal and Axonal Injury via Fcγ Receptor-Mediated Inflammation.Comparison of Campylobacter jejuni isolates implicated in Guillain-Barré syndrome and strains that cause enteritis by a DNA microarrayDysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies.Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy.Pathogenesis of Guillain-Barre syndrome.Antiglycolipid antibodies in Guillain-Barré syndrome and related diseases: review of clinical features and antibody specificities.Action mechanism of corticosteroids to aggravate Guillain-Barré syndrome.Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy.The immunobiology of Guillain-Barré syndromes.Anti-ganglioside antibodies alter presynaptic release and calcium influxGuillain-Barré syndrome and anti-ganglioside antibodies: a clinician-scientist's journey.Basic and clinical aspects of autoimmune disorders in peripheral nerves.Circulating memory T follicular helper subsets, Tfh2 and Tfh17, participate in the pathogenesis of Guillain-Barré syndrome.Gangliosides as targets for autoimmune injury to the nervous system.Campylobacter sialyltransferase gene polymorphism directs clinical features of Guillain-Barré syndrome.
P2860
Q22251013-D61E4689-A40D-4213-B369-A6B5269BE810Q24676037-28D5AF83-8215-4EED-8D1D-9BF182B95480Q26785669-22E3DF43-BAA8-425F-906C-4E84A5896A79Q26801349-A2EB60B8-6F36-49F8-9085-51173064E9D3Q26825224-4AC0B87F-CCAD-4768-B448-BAFF201BDFB8Q26995291-2DE008E8-8AA8-4498-AC8D-803716CE506CQ27009974-6D1FE17E-DDC3-4954-9C70-3936C1A397B3Q28297319-1BC2AE62-E660-47E8-A79B-66E133712907Q28541538-F442613F-4EA5-4FBC-BC9C-05999B6CCD35Q30415924-60DDC71A-D228-4A50-8443-1F850500350AQ30827235-9E50C614-B31F-4F30-9181-11243EAEEDC0Q31162559-C3B632AA-CE6B-46FD-901E-E93FD010BB0CQ33301762-D744B84E-02A8-4EA2-8435-DFB74E776F42Q33886911-2BFA1D7E-F19C-421D-AE14-846BEC146707Q33975353-BB8859DE-B0D4-4A27-A15C-55F1C8D6C8DEQ34075115-C3E8AE9A-7F52-4D5C-8047-C0D675CF46EFQ34130447-F218C05C-C501-4665-8E5F-DC8D38321809Q34167468-DF0CE26A-D4CC-4BA1-B2E0-62494CF32679Q34235801-5834034C-0F1A-4BCE-821A-53806F65CA7EQ34235867-F707C291-1D12-4EE4-AB2F-CE915FA0AB4DQ34443138-DC26580F-92B5-419B-8A44-A8F6982F559FQ35127031-4B8F88AA-6DD8-437D-8F40-3DB3E86F81B7Q35451424-AA0C5104-F198-4077-98FD-D4EF61565B55Q35455283-344B7E45-EFE1-4509-B0FD-51B86A5E4F0CQ35471156-AF4EAD07-8BC4-44A6-8114-F9D23B8EB419Q35547885-82AFC42F-85EE-4F54-88AD-C4DE73434B10Q35550066-ED21EA20-9D3E-4A1A-AEE1-7C0DD70C2AACQ35713309-465F6BD4-0D04-4222-A73D-3016E37A0BC6Q35780245-01BCA660-0C38-48C8-BAA1-7AEBE245AC8BQ35917297-43F43FD1-36B4-4365-8E49-DA820C2F2C03Q36019417-E456DF85-5DBF-4CA2-BEA1-4294A8867E73Q36045649-3AB5BA9F-14E3-4159-A3BB-0CD0227BF76AQ36143242-B29E2F44-B1FA-42CB-894C-F5AE24D8702DQ36164122-11EE4F50-DA0B-42D9-8B1F-4A742B703B7BQ36168575-D7C74DD8-DF6C-4C9B-9498-2D87F54612F8Q36174702-CA94E11C-60F7-48B4-ADDC-812D04544699Q36459487-3478A094-5513-4386-ACC8-C2E2AF00298AQ36569933-E26462BC-A4B7-4ACB-B692-1272F4899998Q36994582-5A7A17D2-E797-4939-AE67-A626A8C01821Q36994586-49E1DD82-7291-4C68-B7FF-6EBD47421F2E
P2860
Acute motor axonal neuropathy: An antibody-mediated attack on axolemma
description
article
@en
im Oktober 1996 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 1996
@uk
name
Acute motor axonal neuropathy: An antibody-mediated attack on axolemma
@en
Acute motor axonal neuropathy: An antibody-mediated attack on axolemma
@nl
type
label
Acute motor axonal neuropathy: An antibody-mediated attack on axolemma
@en
Acute motor axonal neuropathy: An antibody-mediated attack on axolemma
@nl
prefLabel
Acute motor axonal neuropathy: An antibody-mediated attack on axolemma
@en
Acute motor axonal neuropathy: An antibody-mediated attack on axolemma
@nl
P2093
P356
P1433
P1476
Acute motor axonal neuropathy: An antibody-mediated attack on axolemma
@en
P2093
Arthur K. Asbury
Charlene Hafer-Macko
Chun Yan Li
David R. Cornblath
Guy M. McKhann
John W. Griffin
Kazim Sheikh
Tony W. Ho
P304
P356
10.1002/ANA.410400414
P577
1996-10-01T00:00:00Z